Detecting Receptor Activation in Cancer Tissues
Author Information
Author(s): Dua Rajiv, Zhang Jianhuan, Parry Gordon, Penuel Elicia
Primary Institution: Monogram Biosciences Inc.
Hypothesis
Can a novel proximity assay effectively measure receptor activation in formalin-fixed paraffin embedded (FFPE) tumor specimens?
Conclusion
The study presents a novel approach for detecting and quantifying ligand-receptor interactions in FFPE specimens, which can improve the reliability of receptor activation measurements.
Supporting Evidence
- The novel proximity assay demonstrated a broad range of specificity and was consistent with independent assays.
- c-MET and HGF levels were quantified in various cancer types, showing significant correlations with clinical outcomes.
- The assay can detect receptor activation in archived FFPE human tissue specimens.
Takeaway
Researchers created a new test to see how certain proteins in cancer cells are activated, which can help doctors choose better treatments for patients.
Methodology
The study used antibody proximity-based assays to detect and quantify ligand-receptor complexes in FFPE specimens.
Potential Biases
Potential bias due to the use of specific antibodies that may not represent all receptor activation scenarios.
Limitations
The study may not account for all variables affecting receptor activation in clinical settings.
Participant Demographics
Human Non-Small Cell Lung Cancer (NSCLC) specimens and various cancer cell lines.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website